In BC, patients with NMBIC have been found to have higher PTX3 expression in tumour tissues compared to patients with MBIC, suggesting that the overexpression of PTX3 could be associated with a better prognosis in BC patients [13]. The gene discussed is PTX3; the disease is breast cancer.